One of the most commonly prescribed medications worldwide may have a hidden benefit.
Read More »How Cost and Formulation Affect Patient Adherence to Metformin Therapy
Improving medication adherence can reduce healthcare expenditures while producing healthier patients.
Read More »Examining the Risks of Antihyperglycemic Dual and Triple Therapies for T2D
A closer look at the risk of major adverse events, severe hypoglycemia, and all-cause mortality for commonly used therapies in treating type 2 diabetes.
Read More »Metformin Reduces Presurgical Stress
Metformin was used to reduce the risk of complications associated with surgery in type 2 diabetes patients.
Read More »Systematic Literature Reviews Elucidate Cost-Effectiveness of Diabetes Interventions
$327 billion are spent annually for the treatment and management of diabetes.
Read More »New Technology Leads to Breakthrough in Metformin Mechanism of Action
A new study shows that metformin may have a previously unknown mechanism of action that could lead to new and improved diabetes medications.
Read More »Study Provides Insight Into Dual and Triple Therapy Options for Diabetes
Danish study makes strong recommendations for diabetes pharmacotherapy beyond metformin.
Read More »Patient-Specific Factors Affect Metformin Adherence
A large UK study investigates which patients may be likely to discontinue metformin therapy.
Read More »Metformin Used to Reduce Complications from Glucocorticoid Therapy
Glucocorticoid therapy is effective in reducing harm from many immune system disorders, but can also cause serious side effects.
Read More »Renal Disease Impact On Long-Term Metformin Use
As we are all familiar with how metformin can impact patients with existing renal disease, researchers aimed to study how far the limitations can be pushed.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.